Dendritic cell control of immune responses.
作者信息
Morel Penelope A, Butterfield Lisa H
机构信息
University of Pittsburgh , Pittsburgh, PA , USA.
出版信息
Front Immunol. 2015 Feb 5;6:42. doi: 10.3389/fimmu.2015.00042. eCollection 2015.
Abstract
摘要
相似文献
1
Dendritic cell control of immune responses.
Front Immunol. 2015 Feb 5;6:42. doi: 10.3389/fimmu.2015.00042. eCollection 2015.
2
Regulatory B cells control dendritic cell functions.
Immunotherapy. 2011 Apr;3(4 Suppl):19-20. doi: 10.2217/imt.11.34.
3
Engineering vaccines and niches for immune modulation.
Acta Biomater. 2014 Apr;10(4):1728-40. doi: 10.1016/j.actbio.2013.12.036. Epub 2013 Dec 27.
4
Induction of protective therapy for autoimmune diseases by targeted DNA vaccines encoding pro-inflammatory cytokines and chemokines.
Curr Opin Mol Ther. 2004 Feb;6(1):27-33.
5
A high-throughput microparticle microarray platform for dendritic cell-targeting vaccines.
Biomaterials. 2009 Sep;30(25):4168-77. doi: 10.1016/j.biomaterials.2009.04.032. Epub 2009 May 28.
6
Dendritic cell immunotherapy: mapping the way.
Nat Med. 2004 May;10(5):475-80. doi: 10.1038/nm1039.
7
Taming the lions: manipulating dendritic cells for use as negative cellular vaccines in organ transplantation.
Curr Opin Organ Transplant. 2008 Aug;13(4):350-7. doi: 10.1097/MOT.0b013e328306116c.
8
Dendritic cells: master regulators of the immune response.
Cancer Immunol Res. 2013 Sep;1(3):145-9. doi: 10.1158/2326-6066.CIR-13-0102.
9
[Physiology and physiopathology of the immune system: initiation and termination of immune responses].
Bull Mem Acad R Med Belg. 1999;154(6 Pt 2):389-94.
10
Tumor-host immune interactions and dendritic cell dysfunction.
Adv Cancer Res. 2004;92:13-27. doi: 10.1016/S0065-230X(04)92002-7.
引用本文的文献
1
Mesenchymal stem cell-derived exosomes as a plausible immunomodulatory therapeutic tool for inflammatory diseases.
Front Cell Dev Biol. 2025 Mar 10;13:1563427. doi: 10.3389/fcell.2025.1563427. eCollection 2025.
2
Therapeutic role of extracellular vesicles from human umbilical cord mesenchymal stem cells and their wide therapeutic implications in inflammatory bowel disease and other inflammatory disorder.
Front Med (Lausanne). 2024 Jul 30;11:1406547. doi: 10.3389/fmed.2024.1406547. eCollection 2024.
3
Mesenchymal Stem Cell-derived Exosomes: Novel Therapeutic Approach for Inflammatory Bowel Diseases.
Stem Cells Int. 2023 Apr 4;2023:4245704. doi: 10.1155/2023/4245704. eCollection 2023.
4
Hypoxia-inducible factor-1 drives divergent immunomodulatory functions in the pathogenesis of autoimmune diseases.
Immunology. 2021 Sep;164(1):31-42. doi: 10.1111/imm.13335. Epub 2021 Apr 27.
5
Intestinal mycobiota in health and diseases: from a disrupted equilibrium to clinical opportunities.
Microbiome. 2021 Mar 14;9(1):60. doi: 10.1186/s40168-021-01024-x.
6
Antigen-Conjugated Silica Solid Sphere as Nanovaccine for Cancer Immunotherapy.
Int J Nanomedicine. 2020 Apr 22;15:2685-2697. doi: 10.2147/IJN.S242463. eCollection 2020.
7
Alum as an adjuvant for nanoparticle based vaccines: A case study with a hybrid nanoparticle-based nicotine vaccine.
Nanomedicine. 2019 Aug;20:102023. doi: 10.1016/j.nano.2019.102023. Epub 2019 Jun 10.
8
Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function.
Front Immunol. 2018 Nov 9;9:2538. doi: 10.3389/fimmu.2018.02538. eCollection 2018.
9
Oral myeloid cells uptake allergoids coupled to mannan driving Th1/Treg responses upon sublingual delivery in mice.
Allergy. 2018 Apr;73(4):875-884. doi: 10.1111/all.13396. Epub 2018 Jan 31.
10
Characterization of respiratory dendritic cells from equine lung tissues.
BMC Vet Res. 2017 Nov 6;13(1):313. doi: 10.1186/s12917-017-1240-z.
本文引用的文献
1
Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14(+)HLA-DR(lo/neg) Cells): The Gateway to Improved Responses.
Front Immunol. 2014 Apr 4;5:147. doi: 10.3389/fimmu.2014.00147. eCollection 2014.
2
Combinatorial cytokine code generates anti-viral state in dendritic cells.
Front Immunol. 2014 Feb 26;5:73. doi: 10.3389/fimmu.2014.00073. eCollection 2014.
3
Global Inhibition of DC Priming Capacity in the Spleen of Self-Antigen Vaccinated Mice Requires IL-10.
Front Immunol. 2014 Feb 17;5:59. doi: 10.3389/fimmu.2014.00059. eCollection 2014.
4
Stressful presentations: mild cold stress in laboratory mice influences phenotype of dendritic cells in naïve and tumor-bearing mice.
Front Immunol. 2014 Feb 10;5:23. doi: 10.3389/fimmu.2014.00023. eCollection 2014.
5
Regulatory dendritic cells for immunotherapy in immunologic diseases.
Front Immunol. 2014 Jan 31;5:7. doi: 10.3389/fimmu.2014.00007. eCollection 2014.
6
Rapid detection of dendritic cell and monocyte disorders using CD4 as a lineage marker of the human peripheral blood antigen-presenting cell compartment.
Front Immunol. 2013 Dec 27;4:495. doi: 10.3389/fimmu.2013.00495. eCollection 2013.
7
Dendritic cells in cancer immunotherapy clinical trials: are we making progress?
Front Immunol. 2013 Dec 13;4:454. doi: 10.3389/fimmu.2013.00454.
8
Dendritic cell subsets in type 1 diabetes: friend or foe?
Front Immunol. 2013 Dec 6;4:415. doi: 10.3389/fimmu.2013.00415.
9
Therapeutic use of dendritic cells to promote the extranodal priming of anti-tumor immunity.
Front Immunol. 2013 Nov 29;4:388. doi: 10.3389/fimmu.2013.00388.
10
An updated view of the intracellular mechanisms regulating cross-presentation.
Front Immunol. 2013 Nov 22;4:401. doi: 10.3389/fimmu.2013.00401.
Zotero 插件